Ticker Scorecard - SLS Basics Company: SELLAS Life Sciences Group, Inc. IPO Date: April 1, 2008 Sector: Healthcare Industry: Biotech Market Cap: $99.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.40% Avg Daily Range (30 D): $0.07 | 5.71% Avg Daily Range (90 D): $0.05 | 4.21% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): 3.71M Avg Daily Volume (90 D): 1.93M Trade Size Avg Trade Size (Sh.): 169 Avg Trade Size (Sh.) (30 D): 462 Avg Trade Size (Sh.) (90 D): 443 Institutional Trades Total Inst.Trades: 30 Avg Inst. Trade: $1.07M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.77M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 87.76K     News Nov 5, 2024 @ 2:55 PM SELLAS Life Sciences to Present at the 66th Americ... Source: Sellas Life Sciences Group, Inc. Jul 16, 2024 @ 1:06 PM SELLAS Announces U.S. FDA Rare Pediatric Disease -... Source: Sellas Life Sciences Group, Inc. Jul 1, 2024 @ 11:00 AM Solaris and Warints and Yawi Communities Correct t... Source: Solaris Resources Jun 25, 2024 @ 10:30 AM Solaris Reports 11,570 g/t Silver and 12.3 g/t Gol... Source: Solaris Resources Jun 24, 2024 @ 1:05 PM SELLAS Announces U.S. FDA Rare Pediatric Disease D... Source: SELLAS Life Sciences Group, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.68 $-.1 $-.13 Diluted EPS $-.68 $-.1 $-.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -32.28M $ -7.11M $ -7.47M Operating Income / Loss $ -32.77M $ -7.33M $ -7.62M Cost of Revenue $ M $ M $ M Net Cash Flow $ -1.44M $ M $ M PE Ratio     Splits Nov 08, 2019:   50:1 Jan 02, 2018:   30:1 Nov 14, 2016:   20:1